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ABSTRACT:
BACKGROUND: Valid and reliable tools to assess lymphedema are necessary to accurately
evaluate status and to objectively document and measure the results of interventions.
Understanding the advantages and disadvantages of each measure can inform the clinician’s
choice of the appropriate tool to be used in the clinic or research setting. PURPOSE: To identify
reliable and valid measurement techniques which are sensitive to change for assessing edema
volume or soft tissue change in the lower extremities or genital region of patients with
lymphedema. METHODS: A systematic review of the literature was conducted to assess the
published psychometric properties and clinical feasibility of each method identified. Task Force
members independently reviewed each measure using the Cancer EDGE Rating Form.
RESULTS: Water displacement and circumferential measurement methods by tape measure
were both rated as Highly Recommended to quantify lower extremity limb volume. Water
displacement was determined to be the gold standard by which all other assessments of volume
are benchmarked. Optoelectric volumetry and bioelectric impedance analysis were both rated as
Recommended, and ultrasound was rated Not Recommended. CONCLUSION: The Urogenital
Cancer EDGE Task Force highly recommends water displacement and circumferential tape
measurement for use as reliable methods for assessment and documentation of change of limb
volume in this patient population. Early detection of subclinical lower extremity lymphedema in
this patient population remains challenging as there is no ‘index’ limb that can be proven to be
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uninvolved in a patient population with documented pelvic node dissection/irradiation. No
articles were found to support valid and reliable genital lymphedema volume measurement.
KEYWORDS: Psychometrics, measurement, limb volume, edema, urogenital neoplasms
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INTRODUCTION:
Urogenital cancers impact over 5 million Americans, with an estimated 426,000 new
cases annually.1 Urogenital cancers typically affect the urinary system (kidney and related
anatomy, bladder) or the genitals (including ovaries, uterus, cervix, testis, vulva, prostate, and
penis). Mortality estimates for 2017 are approximately 90,000 individuals, with five-year
survival rates ranging from 68% for all stages of cervical cancers, to 99% for all stages of
prostate cancers.2 The magnitude of impact of effective treatments on life expectancy suggests
that these individuals will live for many years after a cancer diagnosis. It is therefore important
that ongoing monitoring of late and long-term effects of cancer treatment take place to help these
individuals return to the level of function and quality of life prior to the cancer diagnosis.
Most urogenital cancers are treated with some combination of surgery, radiation, and
chemotherapy. Surgeries range from removal of the involved organ (oophorectomy,
hysterectomy, prostatectomy, etc.), and often involve pelvic lymph node dissection to determine
the extent of cancer. Radiation to either the tumor bed and/or the groin lymph nodes impacts the
tissues treated as well, with well documented radiation fibrosis resulting from treatment further
compromising the pelvic/groin lymphatic flow.3 The incidence of lymphedema of the lower
extremities and groin varies from 21-36%4,5 among women surgically treated for endometrial,
cervical, or ovarian cancer, and 34% among a mixed population of urogenital cancers.6 The
development of lymphedema of the lower extremities and genitalia results in both functional
impairments and marked decline in quality of life. In a study investigating the prevalence of
symptoms associated with lower limb lymphedema, all of participants with lymphedema
reported difficulty walking, and more than 75% reported achiness and pain.6 Furthermore,
among a population of individuals with lower extremity lymphedema, participants’ baseline
4

quality of life scores on the 36-Item Short Form Survey (SF-36) were approximately 20% lower
than that of a healthy population.7,8 The presence of lower extremity lymphedema negatively
impacts both functional abilities and quality of life, and the need to identify and manage this
chronic disease is clear in order to mitigate these negative effects.
While no universally accepted standards exist to clinically diagnose the presence of
lymphedema, evidence exists to guide this clinical judgement. Typically, a clinical diagnosis of
lymphedema is based on a difference in limb volume, either from a baseline measure or in
comparison to a contralateral limb. The International Society of Lymphology (ISL), in their
2016 Consensus Document on the Diagnosis and Treatment of Peripheral Lymphedema,
identifies a multi-stage classification system for lymphedema: Stage 0 is subclinical, such that
while some symptoms of heaviness, achiness, or sense of tightness are felt by the individual, the
lymphedema is not visible; Stage I is early lymphoma that reverses with elevation; Stage II
manifests pitting without reversal with elevation; and Stage III is considered lymphostatic
elephantitis.9 Furthermore, the ISL Consensus Document suggests that minimal change is
greater than 5% but less than 20%, moderate is 20-40%, and severe is greater than 40%.9 Other
evidence suggests that preclinical lymphedema is characterized by a 3-5% difference in limb
volume, while a 5% difference is considered indicative of early lymphedema.10,11 Still others
have used differences of 10%, 200 ml, or 2cm of circumference as the onset of lymphedema.12
The monitoring of limb volume change is the most common method to identify lymphedema and
its earliest development, although indirect methods of measuring lymphedema are also
employed. Most direct limb volume measurements are completed using water displacement, tape
measure circumferential measurement, or optoelectric volumetry, while indirect measures
include bioelectrical impedance analysis or ultrasound.
5

Accurate assessment of an individual is critical to identify impairments which
drive rehabilitation treatment decisions and to monitor effectiveness of interventions. Following
a call by Rebecca Craik in the 2005 McMillan lecture that the profession of physical therapy
agree on the best outcome measures, the American Physical Therapy Association (APTA)
Section on Research advocated for the determination of a core set of valid and reliable
measurement tools. The identification of and support for particular tools are incorporated into the
Evidence Database to Guide Effectiveness (EDGE). The Neurology Section (now the Academy
of Neurological Physical Therapy) led the inaugural reviews of outcomes measures for stroke,
traumatic brain injury, and multiple sclerosis populations. These reviews used a four-point
ranking scale from Highly Recommended to Not Recommended. The Oncology Section adopted
the procedures of the Neurology EDGE task forces, modifying the ranking scale to five levels,
expanding the definition of “Unable to Recommend” (Figure 1).13 To date, the Oncology Section
has completed 14 reviews in breast cancer, three reviews in prostate cancer, five reviews in head
and neck cancer, and one review in colon cancer. In 2016, the Academy of Neurologic Physical
Therapy modified the ranking scale, and the Oncology Section adopted the new scale (Figure 2)
for reviews going forward.14 While this review was completed prior to the adoption of the new
rating scale, the original rankings determined by the task force remain consistent with the new
ratings. In light of the need to identify a core set of outcome measures for lymphedema among
the urogenital cancer population, the purpose of this systematic review is to identify reliable,
valid, responsive, and clinically feasible methods to measure lower limb and genital
lymphedema.
METHODS
Search Strategy
6

The authors conducted a systematic review of methods and tools to clinically measure lower
extremity limb and genital lymphedema in urogenital cancers in order to identify reliable, valid,
and clinically feasible methods to employ in daily practice. The primary literature search took
place August through September 2015 using six electronic databases: Google Scholar,
PubMed/Medline, CINAHL, Web of Science, Cochrane Review, and PEDro. Primary search
terms that were used included: lymphedema, lower extremity, limb volume, measurement of
limb volume, and genital lymphedema. Additional search terms that described the measurement
of lower extremity limb volume and lymphedema, and genital lymphedema in addition to the
names of specific clinical measuring tools can be found in Appendix A. Secondary searches
through bibliographic review of oncology journals and key research articles took place between
October and December 2015.
Article Selection
To be included in this review, studies (1) were published in English; (2) clinically measured limb
volume by direct or indirect means preferably of the lower extremity, and/or genital
lymphedema; (3) reported psychometric properties; (4) presented methods considered clinically
feasible in a typical physical therapy practice; and (5) included adults (≥ 18 years). Measures
which are not available to the physical therapist, such as lymphoscintography, fluorescence
lymphography, or magnetic resonance imaging, were not included. Additionally, self-reported
measures of measuring lymphedema were not included, as this review is focused specifically on
objective clinical measures. Included articles were considered if published from January 1, 1996
– present, unless a study published prior to 1996 was deemed a key article. Research focusing
on participants with lower extremity or genital lymphedema as a result of urogenital cancers took
first priority, followed by upper extremity lymphedema and/or vascular disorders and venous
7

insufficiency. While searching the databases, when other patient populations in which limb
volume measurements were investigated, such as lower extremity amputations, met all other
inclusion criteria, these articles were included when no other evidence in the cancer population
was available. While it may appear that the research in upper extremity lymphedema, vascular
disorders or venous insufficiency, and residual limbs are not applicable to this review, the
methods of volume measurement, whether water displacement or use of a truncated cone, are
based in principles of physics and mathematics and do not change based on the item measured.
After retrieving all articles, duplicates were removed, and studies were screened on the basis of
title and abstract initially, followed by review of full-text.
Data Extraction and Analysis
Teams of two reviewers independently performed data extraction using the Cancer EDGE Task
Force Rating Form (available online). Psychometrics included in the Cancer EDGE Task Force
Rating Form consisted of reliability, validity, ceiling/floor effects, sensitivity to change, and
clinical utility. The following criteria were applied to determine the strength of the psychometric
properties: excellent reliability = >0.90; good reliability = 0.76-0.89; moderate reliability = 0.500.75; and poor reliability <0.50.15 Concurrent, discriminative, criterion-related, and construct
validity values are reported when available, as well as measures assessing responsiveness to
change such as minimal detectable change (MDC) and minimal clinically important difference
(MCID). In the absence of these common statistical calculations, the coefficient of variation was
reported. Determining clinical usefulness was based on equipment needed, cost, ease of use,
scoring/interpretation, and availability of normative data. Outcome measures that directly or
indirectly measured lower extremity and genital lymphedema were categorized into one of five
tools: (1) Water Displacement, (2) Tape Measure, (3) Optoelectric Volumetry, (4)
8

Bioimpedence, and (5) Ultrasound. Each reviewer then rated the measure using the original
Cancer EDGE Rating Scale. Any discrepancies in ratings were discussed with all four reviewers
until consensus was obtained.
RESULTS:
The initial literature search using terms outlined in Appendix A, alone or in combination,
yielded 181,658 articles. After screening for titles and abstracts and removing any duplicates, 66
articles were identified for subsequent review. An additional eight studies were found on
secondary search. No articles were found that met eligibility criteria for measurement of genital
lymphedema. After applying inclusion/exclusion criteria (articles were removed which did not
have psychometric properties of interest, or were not published in the date range specified, or
were not conducted within populations previously identified), a total of 33 articles were
reviewed. Some of the studies included psychometric analysis of more than one measure of
lymphedema such that the number of articles reviewed for each tool is not mutually exclusive.
The numbers reviewed by category are: Water Displacement (11), Tape Measure (15),
Optoelectric Volumetry (6), Bioimpedence (12), and Ultrasound (1). Figure 3 outlines the flow
diagram for the literature search.
The outcome measures, ratings, and strengths and weaknesses are summarized in Table
1, while Table 2 presents the psychometric properties of the Highly Recommended and
Recommended measures for measurement of lower extremity lymphedema. Lastly, Table 3
summarizes the clinical usefulness of the recommended measures for lower leg lymphedema.
Water displacement and tape measure circumferential measurement methods scored a 4,
and are Highly Recommended by the EDGE Task Force on Urogenital Cancers. Both measures
have been extensively tested and used to measure limb volume in persons with lower extremity
9

edema or lymphedema. Two other measures, optoelectric volumetry and bioimpedance, are rated
3, or Recommended, based on limitations in clinical utility. The use of ultrasound was not
recommended (rating of 1) as a measure of lower extremity lymphedema due to a lack of
available psychometric evidence for use and poor clinical utility. Furthermore, no clinical
method can be recommended to measure genital lymphedema as measures reported on in the
literature are limited to lymphangiography and magnetic resonance lymphography.
DISCUSSION
Based on the chronic nature of lymphedema, the accurate and reliable assessment of limb
volume is crucial to detect lymphedema, and to monitor change in limb volume or amount of
lymphedema over time. As lymphedema may not be visibly apparent in its earliest stages,
ongoing monitoring of the limb at risk is important to detect any change over time. Limb volume
as changes as small as 3% have been documented as pre-clinical lymphedema in a population of
women with breast cancer related lymphedema.10 It is reasonable to extrapolate these findings in
lower extremity lymphedema in the absence of other research support, and support the need to
continue to monitor the limb at risk. Direct or indirect measures of lymphedema (limb volume or
impedance ratios) can be recorded at baseline prior to medical intervention, and used in
comparison to a contralateral normal limb, if available, or the same limb over time, to assess and
track the response to treatment. Long term, measurements allow for monitoring of the success of
the self-management skills which the individual employs. Water displacement, circumferential
measurement with a tape measure, optoelectric volumetry, and bioelectrical impedance analysis
are recommended tools to monitor lower extremity limb volume. While the research available
lacks specific data indicating how responsive each of these measures are, those measures which

10

can accurately detect small levels of change, such as a 3% volume change or a difference in
impedance ratios between limbs, are indicated for use to monitor change in this population. .
Water Displacement
Water displacement is a method for assessing volume used since first described by Archimedes
in Ancient Greece. Archimedes Principle, a body submersed in a liquid loses weight equal to that
of the volume of liquid that it displaces, provides the basis for limb volume measurement in
water.16 Water displacement as a method to calculate the volume of a limb is reproducible using
a standardized container, standardized temperature of the water and room, standardized
immersion of the limb at the same depth and position, and a standardized way to measure the
displaced water.17,18 Measuring displaced water is most often done by volume, including the use
of a transducer equipped volumeter, although some studies used the weight of the displaced
water.17,18 In either method, the involved limb is submerged in a container of water, generally a
volumeter, in the same position and to the same depth on each measurement occasion. Limb
volume is then based on the measurement of the water displaced.
Water displacement is considered the ‘gold standard’ of volume measurement to which
all other methods are compared.19 Most studies reviewed which described the use of water
displacement measured volumes to the level of the knee, and were done in patients with venous
insufficiency or peripheral vascular disease.17,18 There were no studies found for full leg water
displacement, most likely reflecting the difficulty that would be encountered in creating a
container for volumetric measurement of differing length legs and the attendant difficulty in
achieving insertion of a full leg into the device. Water displacement was found to have a high
day to day reliability in repeated measures done over five episodes. Test-retest values ranged
from r=.95-.99, and the mean percent change in volume measurements ranged between 011

.37%.16 Overall inter-rater reliability of this method varies from ρ=0.95, where ρ is the
intrasubject correlation coefficient, based on an analysis of variance,20 to ICC=0.99.21 One study
examined the minimum percent change of the volume of the leg and determined the MDC to be
22.2-23.4%.22 These excellent psychometric properties make water displacement a Highly
Recommended measure of lower extremity limb volume.
The advantages of water displacement as a method for volume assessment are low cost
(generally less than $400) with high accuracy in assessing the most distal portion of the limb.19
Volumeters are generally made of plexiglass with a spout and come with a calibrated cylinder
collecting vessel. High clinical feasibility, however, may be hindered by the time investment to
measure (filling, draining, cleaning), the potential excess size of a limb not fitting a volumeter,
and the inability to measure the full limb to the groin.
It should be noted that a contraindication to using water displacement is the immersion of
limbs with open wounds. A compelling reason for the importance of infectious disease
precautions is due to the fact that those with lymphedema have a known compromise in their
immune response with a greater risk of cellulitis.23 Another limitation in the use of volumeters
for individuals with lower extremity lymphedema is the possibility of an excessive size of the
patient’s leg. It is not unusual in some clinical settings to see patients with calf circumferences in
excess of 120 cm, far exceeding the size of volumeters that are available commercially.
Circumferential Measurement by Tape Measure
Taking circumferential measurements at regular intervals with a non-elastic tape measure
is the most widely used clinical method to determine the presence of lymphedema and assess
volume changes when monitoring response to treatment. The best tape measures have several
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important attributes: are made of non-stretch material, are easily cleaned with alcohol swabs, and
have clearly and easily discernible markings and an easily seen zero mark. The need for
consistent tensioning of the tape can be addressed by the use of a tape measure with a spring
tension gauge at the zero end assuring the exact same pull with each application. However,
studies done of circumferential measurement without the use of this tension gauge have
demonstrated good inter- (ICC=0.97) and intrarater reliability (ICC=0.92-0.99) in both upper and
lower limb measurement.24,25
Reliable and reproducible measurements require a standardized positioning of the patient
and establishment of reproducible landmarks for marking intervals of measurement. It is
important to utilize a straight measure of intervals marked for measurement rather than a
contoured laying on of the tape on the limb as the contour of an abnormally shaped
lymphedematous limb can change dramatically during treatment and lead to errors in subsequent
markings of intervals for repeated measurement. Boards with a footplate provide this rigid
straight method to mark intervals more consistently. Landmarks for the zero interval also
improve the reliability of the resultant and subsequent measurements. In several studies, the
landmark chosen is the malleoli ,17-19 while in others26,27 the heel is the landmark. In practice, the
malleoli can be almost obliterated in the lymphedema patient at evaluation, so that a base of heel
or distance from the floor (the footplate) to the bend of the ankle is least likely to change with
treatment and should be used as the zero interval.28 The distance between intervals varies
depending on the study; 4 cm and 10 cm intervals are reported.17,27,29 Both methods are reliable
and valid, and correlate highly with each other (r>.99) however, the 4 cm method may better
account for abnormal lobules in advanced lymphedema.24,29 Whichever interval is used for
measurement, values are typically entered into an appropriate truncated cone formula to
13

determine limb volume. The Frustrum or truncated cone formula is more accurate in assessing
limb volume than a cylinder formula, as the limb is roughly the shape of a cone.30
The advantages of using a tape measure for volume measurement are cost (low) and
accessibility (high) in the clinical setting. This measurement can also be done even if the patient
has wounds or is unable to assume a standardized position for measurement by water
displacement. When compared to the gold standard water displacement, the validity is excellent,
(ICC=0.93 – 0.98), except in grade 1 edema where the correlation between measures was
moderate (r=0.45).17,26,27 Reliability is also excellent: test-retest reliability in a 1-2 week
timeframe was excellent (ICC=0.94) and good (ICC=0.82) long term; interrater and interrater
reliability were both excellent (ICC=0.89-0.99 and ICC=0.82-99, respectively).19 Minimal
ceiling or floor effects are present using a tape measure measurement, however one study
reported that when the leg volume difference is >11%, tape measurement overestimated the
volume difference as compared to water displacement.17 One study examined the SEM and
determined this to approximately 84 ml or 0.64% of lower leg volume.31 These sound
psychometric properties and high clinical utility make this tool highly recommended by the
EDGE task force.
The disadvantage of tape measurement method is time needed for multiple measurements
and then calculation for comparison with contralateral ‘normal’ limb or for comparison to pretreatment volumes. The time to calculate volume can be mitigated through the use of previously
formatted spreadsheets such that simply entering circumferential values will render total volume
and percent volume difference. Of clinical importance is the consideration that in lower
extremity lymphedema, the lymphatic compromise is often bilateral despite presentation of
swelling in only one limb. Post treatment measurements often demonstrate a volume reduction in
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what was thought to be a ‘normal’ limb due to the focus in Complete Decongestive Therapy
(CDT) on the proximal, intact lymphatic system. This is consistent with the physiological fact
that there needs to be an increase of 20-30% in the normal interstitial volume before it is
clinically apparent.32 Therefore, comparison over time may be a more clinically relevant
measure.
Optoelectric Volumetry
Optoelectric volumetry, or perometery, is an assessment of limb volume that utilizes an
array of infrared beams oriented via a square frame at right angles to each other. As the frame,
tracking on a carriage, is passed over a limb in either a horizontal or vertical configuration, the
limb volume is calculated using a computerized algorithm. The validity of optoelectric
volumetry was established in comparison to water displacement and ranges from r=0.97-0.99.3335

Test-retest reliability is excellent with an ICC=0.99.18,36 Intrarater reliability is reported as

excellent, with an ICC≥0.99.37,38 The repeated measures coefficient of variation was reported as
0.13.36
The advantage of optoelectric volumetry is that a highly accurate limb volume can be
calculated very quickly once the equipment is on and ready for use. For the commercially
available Perometer, additional benefits include optional compression garment measurement as
the software reports the actual circumference at the standardized landmarks used by German
manufacturers for garment manufacturing.
The main disadvantages to the Perometer being used in the clinical setting are the cost
and size of the equipment. The equipment is large, requiring approximately half of the size of a
typical treatment room. The purchase price in 2015 was $16,000-26,000 USD, with one primary
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manufacturer: Pero-System GmbH in Germany (Wuppertal, Germany). Whether to utilize a
horizontal or a vertical system is dependent on the primary population to be measured. Although
either unit can measure both upper extremity and lower extremity, a horizontal unit requires that
the mid-frame be positioned at chair height for the lower extremity while the individual must
bend over to measure the upper extremity in a vertical unit. The size of the frame limits the
extent to which the unit can traverse proximally up the limb and reduces the volume calculation
possible for the limb. Accuracy of the measurements depend on correct horizontal positioning of
the limb and patients with limited range of motion may not be able to be correctly
positioned.34,35,37 Newer optoelectric volumetry units, such as that designed by Skanlab, are
being developed for clincial use.39 It is possible that other optoelectric volumeter units may be
available commercially in the future.
Bioelectrical Impedance Analysis
Multi-frequency bioelectrical impedance analysis (BIA) is a non-invasive assessment
technique that utilizes a very small alternating current which is passed through tissue creating a
measure of impedance, or resistance to flow of the current. The current moves through the path
of least resistance in the tissues measuring the resistance through the water content of the
intracellular and extracellular portions of the soft tissue. Low frequency current passes through
the extracellular fluid, while high frequency current passes through the intracellular fluid. BIA
then measures both total resistance and the resistance of the extracellular fluid quantify the
impedance. This resistance is compared to an unaffected limb, creating an impedance ratio.22
Originally tested in women with breast cancer-related lymphedema, if this inter limb impedance
ratio exceeds the mean ratio plus three standard deviations, a diagnosis of lymphedema is

16

confirmed.40,41 Like other methods of volume assessment, pre-operative values for comparison
post-surgery are helpful for early diagnosis.40
Bioimpedance devices utilize four or eight electrode arrays; the eight electrode systems
are considered to be more accurate.42 Recommendations for reproducibility included: taking
measurements at the same time with a constant ambient temperature, and cleaning the sites with
alcohol or wet wipes before standardized application of the electrodes.41,42 In a study comparing
bioelectrical impedance values between individuals diagnosed with lymphedema via
lymphoscintography and controls, BIA accurately identified those with lymphedema.43 Intratester reliability ICC=0.88 in a population with lymphedema due to filariasis.44 The predictive
value of BIA was 53.2% in this same population.44 The sensitivity of BIA to monitor change was
excellent in two studies: 100% sensitivity is reported in a population with lymphatic filariasis,
and treatment differences compared to baseline were highly significant (p<.001) in patients with
pedal edema.22,44
The most prominent advantage of BIA is that it can detect the onset of lymphedema
before clinical signs of swelling become apparent.40 It can be completed in 5-15 min depending
on the number of repeated measures made and is an accessible technology for pre-operative
values for reference in the post-operative period. A reference range has been established for the
impedance ratio for the legs without pathology, allowing for criteria for the diagnosis of early
lymphedema in the leg.41
The disadvantages of BIA are that it remains an assessment that, with the current
bioelectrical impedance protocol which creates a ratio comparing the unaffected and affected
limb, is useful only for unilateral lymphedema risk.41 In most urogenital cancers, pelvic lymph
node dissection and/or radiation affects the lymphatic drainage patterns of both lower extremities
17

even in a patient who presents with unilateral swelling. Another disadvantage of BIA is that it is
useful primarily for the assessment of early stage (0-1) lymphedemas, as in the later stages of
lymphedema the extracellular fluid has been replaced to a large degree by fibrous tissue.45 When
this has occurred, BIA is not helpful for diagnosis or monitoring of change over time. Lastly, the
electrodes are single use and therefore have a cost associated with each use.
Considerations in measuring limb volume
Two cautionary issues arise when monitoring the lower limb at risk in urogenital cancer.
First, there is a significant difference in volume assessments in the lower extremity when the
entire limb is included in the measurements since the majority of swelling is often only below the
knee.27 The length of the limb being measured, whether to the knee as is typical in water
displacement, or to the groin including the thigh, can also impact accuracy and interpretation.
Specifically, as the amount of change in the smaller lower leg may be only a small percentage of
the whole limb, the size of the thigh may mask the amount of change of the lower leg. Rather,
using clinical judgment incorporating patient symptom report and clinician expertise, the
measures used should be to the level of greatest involvement. If this is not amenable to water
displacement, clinical judgment then determines that water displacement should not be used.
However, if only the lower leg is involved, then this method may be appropriate. Ideally it is
clinically important to have measurements of the full thigh pre-treatment because there is also a
possibility of ‘fluid shift’ into the proximal limb or genitals during treatment which must be
recognized and addressed, and this is most easily accomplished via circumferential
measurements with a tape measure.
The second consideration is the possibility of bilateral lower limb involvement because
this limits the usefulness of limb to limb comparisons. For this reason, it is essential that
18

baseline measures are taken prior to medical intervention. The Prospective Surveillance Model
developed for women with breast cancer includes baseline assessment and ongoing periodic
monitoring.46 This model could easily be adopted for use in the urogenital population. These
baseline measures, then, would serve as a comparison for any changes in the lower limbs.
Ultrasound is not recommended by the urogenital cancer EDGE Task Force. The limited
psychometric properties, in conjunction with decreased clinical utility, particularly cost and
training, do not support its use for assessment of limb volume in this population. In a study
examining the diagnostic validity of ultrasound, skin thickness was greater in the involved limb
compared to the non-involved limb (p<0.05) among women with breast cancer related
lymphedema,47,48 yet examining the ability to detect change over time was poor as the change in
skin thickness with a decrease in volume was only minimally correlated (r=.37).49 Furthermore,
no studies examining reliability were found.
Limitations
This topic of lower limb lymphedema in the urogenital cancer population has not been
studied to the extent seen in secondary lymphedema related to breast cancer. This resulted in far
fewer studies in which the population of interest was available. The authors recommend that
research be focused on accurately measuring lymphedema, whether directly or indirectly, in the
urogenital cancer population. Additional research in the development of optoelectric volumetric
tools is warranted in order for these tools to become more clinical useful. Furthermore, it is
essential to develop reliable and valid clinical methods to measure genital lymphedema, and as
this research need is significant, it should be prioritized. This literature search was completed in
September of 2015, and therefore any studies published thereafter with psychometric properties
may not be included in this review. Newer studies may provide additional information to
19

evaluate these measures, and the use of bioelectrical impedance analysis is a growing in use as
measurement technique of lymphedema. We recommend these ratings be reviewed in
approximately five years as new evidence becomes available. As lymphedema is a world-wide
problem, limiting the search to the English language may have resulted in eliminating important
research published elsewhere. All recommendations made by this Task Force are issued based
on the best available evidence at the time of analysis. The reader is encouraged to employ
clinical judgment, expertise, and to take into account patient values when implementing these
recommendations.
CONCLUSION
This systematic review evaluated methods to measure lymphedema in the urogenital
cancer population, focusing on lower limb edema/lymphedema. Use of water displacement or
circumferential measures with a tape measure were Highly Recommended by the Urogenital
Cancer EDGE Task Force. These measures have sound psychometric properties, and high
clinical feasibility. Further research is needed in valid and reliable methods to measure genital
lymphedema.
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Table 1: Summary of Outcome Measures
Measure

Water Displacement

Tape Measure

Optoelectric volumetry

Bioelectrical Impedance

Ultrasound

EDGE
Rating

4

4

3

Strengths/Weaknesses
•
•
•
•
•

Gold standard method to measure volume
Valid in multiple populations
Inexpensive
Inconvenient – requires a wet room
Time investment for infection control
practices
• Difficult to submerge full lower limb

•
•
•
•

Inexpensive
Accurate
Reliable
Validated against the gold standard

•
•
•
•
•
•

Validated against the gold standard
Highly accurate
Quick
Very expensive for clinical use
Requires space
Not able to acquire as a medical device
outside of Europe

3

• Effective in early determination of volume
changes
• Expensive – unit and electrodes
• Not as useful in later stage lymphedema

1

• High cost
• High level of training
• Poor responsiveness
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Table 3: Clinical Usefulness of Recommended Measures
Measure

Equipment Needed

Cost

Ease of Use

Scoring/
Interpretation

Normative
Data

Water
Displacement

Yes

Minimal

High

Easy

No

Tape Measure

Yes

Minimal

High

Easy

No

Perometer

Yes

High

Moderate

Easy

No

Bioelectrical
Impedance

Yes

High

High

Easy

Yes

30

Table 2: Psychometric Properties of Recommended Measures for Lower Extremity Lymphedema
Measure

Test/Re-Test
Inter-rater
Intra-rater
Reliability
Reliability
Reliability
(ICC)
(ICC)
(ICC)
Urogenital Lymphedema Measures – Highly Recommended
Water
ICC = 0.97ICC = 0.94ICC ≥0.9820,24
16
20
Displacement 0.98 (leg)
0.98 (arm)
(arm)
r = .95-.9916
ICC=0.9921
(leg)
(arm)

Responsiveness
to Change

Validity

CV = 0.72%16
MDC (leg) =
22.2 - 23.4%22

Gold-standard

Tape Measure

SEM = 83.6 ml or
.64% (lower limb
lymphedema)31

Pearson CC of residual limb’s volume and level:51 (leg)
Tibial tubercle= 0.814
4-cm from tibial tubercle=0.892
8-cm from tibial tubercle=0.878
Distal end=0.715

ICC=0.94 (1-2
weeks)
ICC = 0.82
(long term)19
(leg)
ICC=0.96 (0.92
-1.00 CI95)50
(leg)
ICC = 0.910.9725 (leg)

Short term (1
week)
ICC=0.9019
Medium term
(2 weeks)
ICC=0.8919
(leg)
Long term (12
weeks)
ICC=0.7819
(leg)
ICC=0.97 0.98 (0.97 –
1.00 CI95)25,50
(leg)
ICC = 0.970.9920 (arm)

Short term (1
week)
ICC=0.9419
(leg)
Long term (12
weeks)
ICC=0.8219
(leg)
ICC=0.99 (0.97
- 1.00 CI95)25,50
(leg)
ICC = 0.95
(0.96-0.99)24,38
(arm)

Effect size (pedal edema): 0.64-0.8522 (leg)

Concurrent Validity:
- water displacement r=.32,52 (leg) r=.93-.9817,27
(arm and leg)
- water displacement for normal limb: r=.55-.6126
(leg)
- water displacement affected limb: r=.75-.8026
(leg)
- CLEMS (computerized volume measurement
system): r = 0.34152 (leg)
- automated volume estimates of legs: r=0.97735
(arm and leg)
- with water displacement for17,26,27 (leg)
- grade 1 lymphedema: r=0.45;
- grade 2 lymphedema: r=0.92;
- grade 3 lymphedema: r=0.92

31

Optoelectric
volumetry

ICC=0.99 (0.98
- 0.99 CI95)18,36
(leg)

ICC ≥ 0.99
(0.99 to
1.00)37,38
(arm)

ICC=0.99737
(leg)

Urogenital Lymphedema Measures – Recommended
Bioimpedance
ICC= 0.95
ICC=0.8844
(0.90 to
(leg)
38
0.98) (arm)
ICC = 0.8844
(leg)

CV = .1336

Concurrent Validity:
- water displacement r=.9733 (leg)
- circumferential measurement with tape
measure34 (arm)
- r=.999 for mannequin limbs
- r=.985 for normal human arms
- r=.988 for upper extremity lymphedema
- strain gauge: r=0.6334 (arm)
- with tape measure ICC=0.99735 (arm and leg)
- with truncated cone total limb volume r=0.9838
(arm)

CV = 15.6 to
17.222 (leg)

In lymphatic filariasis44 (leg)
- Sensitivity = 100%
- Specificity= 21.4%
Validity:
- Bipolar and tetrapolar technique Cronbach’s
alpha = .668 (coefficient of variability <5%
variability in 93% of measures)45 (arm)
- Concordance correlation with perometer r=0.9238
(arm)
- Concordance correlation with truncated cone
total limb volume r=0.8938 (arm)
Positive predictive value = 53.2% (lymphatic filariasis)44
(leg)
Pedal Edema:22 (leg)
- Effect size = .64 to .93

CV – coefficient of variation; ICC – intraclass correlation coefficient; P = intrasubject correlation coefficient; r – Pearson’s correlation coefficient;
UE – upper extremity
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Figure 1: Cancer EDGE Rating Scale
Highly
Recommend

The outcome has good psychometric properties and good
clinical utility; the measure has been used in research on
individuals with or post cancer.

3

Recommend

The outcome measure has good psychometric properties
and good clinical utility; no published evidence that the
measure has been applied to research on individuals with
or post cancer.

2A

Unable to
Recommend at
this time

There is insufficient information to support a
recommendation of this outcome measure; the measure
has been used in research on individuals with or post
cancer.

2B

Unable to
Recommend at
this time

There is insufficient information to support a
recommendation of this outcome measure; no published
evidence that the measure has been applied to research
on individuals with or post cancer.

1

Do not
Recommend

4

Poor psychometrics &/or poor clinical utility (time,
equipment, cost, etc.)
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Figure 2: Cancer EDGE Rating Scale, Updated 2016

4

Highly
Recommended

3

Recommended

2

Reasonable to Use

1

Not Recommended

The outcome measure has excellent psychometric
properties (reliability and validity AND have available
data to guide interpretation) in condition of interest and
excellent clinical utility (≤20 min, equip in clinic, no
copyright payments, easy to score); the measure is free
or reasonably accessible to a broad range of providers.
The outcome measure has good psychometric properties
(may lack some info about reliability, validity,
responsiveness) in the population of interest and good
clinical utility (>20 min, some equip, training, copyright
fee); OR has excellent psychometric properties but is not
free and may require access to specialized testing
equipment that is beyond the means of many clinicians or
clinics.
Limited study in target group; the outcome measure has
good or excellent psychometric properties and clinical
utility in a related population, but insufficient study in
target population to support higher recommendation.
The outcome measure has poor psychometric properties
and/or poor clinical utility
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Identification

Figure 3. PRISMA Flow of literature search.

# of records identified through
database searching:
181,658

# of additional records identified
through other sources:
8

Screening

Records after duplicates removed:
292

Articles
excluded from
title and
abstract review:
90

Articles screened for
eligibility:
158

Eligibility

Full-text articles
assessed for eligibility:
68

Full-text articles
excluded, with
reasons: 35

Included

Articles included in
qualitative synthesis: 33

Water
Displacement
11

Tape
Measure
15

Optoelectric
Volumetry
7

Bioimpedance
12

Ultrasound
3
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Appendix A
Secondary search terms:
Reliability of lymphedema
Reliability of lower extremity
Lower extremity lymphedema
Lower extremity limb volume treatments
Lymphedema treatments
Measure AND lymphedema
Measure AND limb volume
Limb volume AND tape measure
Limb volume AND volumeter
Limb volume AND bioimpedence
Limb volume AND ultrasound
Limb volume AND perometer
Limb volume AND water displacement
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